{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:52:49Z","timestamp":1773885169664,"version":"3.50.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Prolongation of cardiac repolarization (QT interval) represents a dangerous and potentially life-threatening electrical event affecting the heart. Thyroid hormones (THs) are critical for cardiac development and heart function. However, little is known about THs influence on ventricular repolarization and controversial effects on QT prolongation are reported. Human iPSC-derived cardiomyocytes (hiPSC-CMs) and multielectrode array (MEA) systems were used to investigate the influence of 3,3\u2032,5-triiodo-<jats:sc>l<\/jats:sc>-Thyronine (T3) and 3,3\u2032,5,5\u2032-tetraiodo-<jats:sc>l<\/jats:sc>-Thyronine (T4) on corrected Field Potential Duration (FPDc), the in vitro analog of QT interval, and on local extracellular Action Potential Duration (APD). Treatment with high THs doses induces a significant prolongation of both FPDc and APD, with the strongest increase reached after 24\u00a0h exposure. Preincubation with reverse T3 (rT3), a specific antagonist for nuclear TH receptor binding, significantly reduces T3 effects on FPDc, suggesting a TRs-mediated transcriptional mechanism. RNA-seq analysis showed significant deregulation in genes involved in cardiac repolarization pathways, including several QT-interval related genes. In conclusion, long-time administration of high THs doses induces FPDc prolongation in hiPSC-CMs probably through the modulation of genes linked to QT-interval regulation. These results open the way to investigate new potential diagnostic biomarkers and specific targeted therapies for cardiac repolarization dysfunctions.<\/jats:p>","DOI":"10.1038\/s41598-021-04659-w","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T11:02:59Z","timestamp":1641985379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Thyroid hormones regulate cardiac repolarization and QT-interval related gene expression in hiPSC cardiomyocytes"],"prefix":"10.1038","volume":"12","author":[{"given":"Alessandra","family":"Ulivieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Lavra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorenza","family":"Magi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Morgante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Cal\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizio","family":"Polisca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila B.","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Sciacchitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"issue":"6","key":"4659_CR1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0002-9149(94)90742-0","volume":"74","author":"W Zareba","year":"1994","unstructured":"Zareba, W., Moss, A. J. & le Cessie, S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am. J. Cardiol. 74(6), 550\u2013553 (1994).","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"4659_CR2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0735-1097(99)00590-2","volume":"35","author":"T Ikeda","year":"2000","unstructured":"Ikeda, T. et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J. Am. Coll. Cardiol. 35(3), 722\u2013730 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"4659_CR3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/er.2003-0033","volume":"26","author":"GJ Kahaly","year":"2005","unstructured":"Kahaly, G. J. & Dillmann, W. H. Thyroid hormone action in the heart. Endocr. Rev. 26(5), 704\u2013728 (2005).","journal-title":"Endocr. Rev."},{"issue":"8","key":"4659_CR4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.amjmed.2014.03.009","volume":"127","author":"IM Grais","year":"2014","unstructured":"Grais, I. M. & Sowers, J. R. Thyroid and the heart. Am. J. Med. 127(8), 691\u2013698 (2014).","journal-title":"Am. J. Med."},{"issue":"11","key":"4659_CR5","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1001\/jamainternmed.2017.4836","volume":"177","author":"A Bano","year":"2017","unstructured":"Bano, A. et al. Association of thyroid function with life expectancy with and without cardiovascular disease: The Rotterdam study. JAMA Intern. Med. 177(11), 1650\u20131657 (2017).","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"4659_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12916-017-0777-9","volume":"15","author":"Y Ning","year":"2017","unstructured":"Ning, Y. et al. What is the association of hypothyroidism with risks of cardiovascular events and mortality? A meta-analysis of 55 cohort studies involving 1,898,314 participants. BMC Med. 15(1), 21 (2017).","journal-title":"BMC Med."},{"issue":"6","key":"4659_CR7","doi-asserted-by":"crossref","first-page":"e023854","DOI":"10.1136\/bmjopen-2018-023854","volume":"9","author":"B Tayal","year":"2019","unstructured":"Tayal, B. et al. Thyroid dysfunction and electrocardiographic changes in subjects without arrhythmias: A cross-sectional study of primary healthcare subjects from Copenhagen. BMJ Open 9(6), e023854 (2019).","journal-title":"BMJ Open"},{"issue":"1","key":"4659_CR8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3346\/jkms.2007.22.1.114","volume":"22","author":"KH Kweon","year":"2007","unstructured":"Kweon, K. H., Park, B. H. & Cho, C. G. The effects of l-thyroxine treatment on QT dispersion in primary hypothyroidism. J. Korean Med. Sci. 22(1), 114\u2013116 (2007).","journal-title":"J. Korean Med. Sci."},{"issue":"5","key":"4659_CR9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1159\/000141503","volume":"17","author":"O Bakiner","year":"2008","unstructured":"Bakiner, O. et al. Subclinical hypothyroidism is characterized by increased QT interval dispersion among women. Med. Princ. Pract. 17(5), 390\u2013394 (2008).","journal-title":"Med. Princ. Pract."},{"issue":"1","key":"4659_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2265.2001.01295.x","volume":"55","author":"RM Colzani","year":"2001","unstructured":"Colzani, R. M. et al. Hyperthyroidism is associated with lengthening of ventricular repolarization. Clin. Endocrinol. 55(1), 27\u201332 (2001).","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"4659_CR11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/EJE-07-0357","volume":"158","author":"F Galetta","year":"2008","unstructured":"Galetta, F. et al. Changes in heart rate variability and QT dispersion in patients with overt hypothyroidism. Eur. J. Endocrinol. 158(1), 85\u201390 (2008).","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"4659_CR12","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1210\/jc.2006-1017","volume":"91","author":"M D\u00f6rr","year":"2006","unstructured":"D\u00f6rr, M. et al. The relation of thyroid function and ventricular repolarization: Decreased serum thyrotropin levels are associated with short rate-adjusted QT intervals. J. Clin. Endocrinol. Metab. 91(12), 4938\u20134942 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2 Pt 1","key":"4659_CR13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0002-8703(98)70081-X","volume":"135","author":"M Gomberg-Maitland","year":"1998","unstructured":"Gomberg-Maitland, M. & Frishman, W. H. Thyroid hormone and cardiovascular disease. Am. Heart J. 135(2 Pt 1), 187\u2013196 (1998).","journal-title":"Am. Heart J."},{"issue":"6 Pt 2","key":"4659_CR14","first-page":"H1265","volume":"252","author":"O Binah","year":"1987","unstructured":"Binah, O., Arieli, R., Beck, R., Rosen, M. R. & Palti, Y. Ventricular electrophysiological properties: Is interspecies variability related to thyroid state?. Am. J. Physiol. 252(6 Pt 2), H1265\u2013H1274 (1987).","journal-title":"Am. J. Physiol."},{"issue":"1","key":"4659_CR15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-2006-924977","volume":"38","author":"M Owecki","year":"2006","unstructured":"Owecki, M., Michalak, A., Nikisch, E. & Sowi\u0144ski, J. Prolonged ventricular repolarization measured by corrected QT interval (QTc) in subclinical hyperthyroidism. Horm. Metab. Res. 38(1), 44\u201347 (2006).","journal-title":"Horm. Metab. Res."},{"issue":"4","key":"4659_CR16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1540-8159.2009.02310.x","volume":"32","author":"U Guntekin","year":"2009","unstructured":"Guntekin, U. et al. QTc dispersion in hyperthyroidism and its association with pulmonary hypertension. Pacing Clin. Electrophysiol. 32(4), 494\u2013499 (2009).","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"7","key":"4659_CR17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3345\/kjp.2015.58.7.263","volume":"58","author":"YS Lee","year":"2015","unstructured":"Lee, Y. S. et al. The corrected QT (QTc) prolongation in hyperthyroidism and the association of thyroid hormone with the QTc interval. Korean J. Pediatr. 58(7), 263\u2013266 (2015).","journal-title":"Korean J. Pediatr."},{"issue":"1","key":"4659_CR18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1677\/JOE-08-0140","volume":"198","author":"C Van Noord","year":"2008","unstructured":"Van Noord, C. et al. High free thyroxine levels are associated with QTc prolongation in males. J. Endocrinol. 198(1), 253\u2013260 (2008).","journal-title":"J. Endocrinol."},{"issue":"4","key":"4659_CR19","doi-asserted-by":"crossref","first-page":"e59489","DOI":"10.1371\/journal.pone.0059489","volume":"8","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Thyroid hormones and electrocardiographic parameters: Findings from the third national health and nutrition examination survey. PLoS ONE 8(4), e59489 (2013).","journal-title":"PLoS ONE"},{"issue":"24","key":"4659_CR20","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM199806113382401","volume":"338","author":"PJ Schwartz","year":"1998","unstructured":"Schwartz, P. J. et al. Prolongation of the QT interval and the sudden infant death syndrome. N. Engl. J. Med. 338(24), 1709\u20131714 (1998).","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"4659_CR21","doi-asserted-by":"crossref","first-page":"e005485","DOI":"10.1161\/CIRCEP.117.005485","volume":"10","author":"WT O'Neal","year":"2017","unstructured":"O\u2019Neal, W. T. et al. Association between QT-interval components and sudden cardiac death: The ARIC Study (Atherosclerosis Risk in Communities). Circ. Arrhythm. Electrophysiol. 10(10), e005485 (2017).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"2","key":"4659_CR22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2016.245","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi, Y., Inoue, H., Wu, J. C. & Yamanaka, S. Induced pluripotent stem cell technology: A decade of progress. Nat. Rev. Drug Discov. 16(2), 115\u2013130 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"4659_CR23","first-page":"360","volume":"167","author":"J Huo","year":"2019","unstructured":"Huo, J., Wei, F., Cai, C., Lyn-Cook, B. & Pang, L. Sex-related differences in drug-induced QT prolongation and torsades de pointes: A new model system with human iPSC-CMs. Toxicol. Sci. 167(2), 360\u2013374 (2019).","journal-title":"Toxicol. Sci."},{"issue":"11","key":"4659_CR24","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3390\/cells8111331","volume":"8","author":"S Kussauer","year":"2019","unstructured":"Kussauer, S., David, R. & Lemcke, H. hiPSCs derived cardiac cells for drug and toxicity screening and disease modeling: What micro-electrode-array analyses can tell us. Cells 8(11), 1331 (2019).","journal-title":"Cells"},{"key":"4659_CR25","doi-asserted-by":"crossref","first-page":"22.4.1","DOI":"10.1002\/cptx.2","volume":"68","author":"M Clements","year":"2016","unstructured":"Clements, M. Multielectrode array (MEA) assay for profiling electrophysiological drug effects in human stem cell-derived cardiomyocytes. Curr. Protoc. Toxicol. 68, 22.4.1-22.4.32 (2016).","journal-title":"Curr. Protoc. Toxicol."},{"issue":"1","key":"4659_CR26","doi-asserted-by":"crossref","first-page":"11893","DOI":"10.1038\/s41598-019-48174-5","volume":"9","author":"HB Hayes","year":"2019","unstructured":"Hayes, H. B. et al. Novel method for action potential measurements from intact cardiac monolayers with multiwell microelectrode array technology. Sci. Rep. 9(1), 11893 (2019).","journal-title":"Sci. Rep."},{"issue":"11","key":"4659_CR27","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1210\/endo.137.11.8895342","volume":"137","author":"Y Sakaguchi","year":"1996","unstructured":"Sakaguchi, Y., Cui, G. & Sen, L. Acute effects of thyroid hormone on inward rectifier potassium channel currents in guinea pig ventricular myocytes. Endocrinology 137(11), 4744\u20134751 (1996).","journal-title":"Endocrinology"},{"issue":"4","key":"4659_CR28","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1006\/jmcc.1998.0930","volume":"31","author":"CJ Huang","year":"1999","unstructured":"Huang, C. J., Geller, H. M., Green, W. L. & Craelius, W. Acute effects of thyroid hormone analogs on sodium currents in neonatal rat myocytes. J. Mol. Cell Cardiol. 31(4), 881\u2013893 (1999).","journal-title":"J. Mol. Cell Cardiol."},{"issue":"3","key":"4659_CR29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0038-1624289","volume":"24","author":"A Passath","year":"1985","unstructured":"Passath, A., Leb, G. & Goebel, R. The evaluation of free thyroid hormones (FT4 and FT3) in the routine diagnosis of thyroid function. Nuklearmedizin 24(3), 115\u2013121 (1985).","journal-title":"Nuklearmedizin"},{"issue":"9","key":"4659_CR30","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1172\/JCI60047","volume":"122","author":"GA Brent","year":"2012","unstructured":"Brent, G. A. Mechanisms of thyroid hormone action. J. Clin. Investig. 122(9), 3035\u20133043 (2012).","journal-title":"J. Clin. Investig."},{"issue":"2","key":"4659_CR31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrendo.2015.205","volume":"12","author":"PJ Davis","year":"2016","unstructured":"Davis, P. J., Goglia, F. & Leonard, J. L. Nongenomic actions of thyroid hormone. Nat. Rev. Endocrinol. 12(2), 111\u2013121 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"11","key":"4659_CR32","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1016\/S0021-9258(18)32269-5","volume":"258","author":"JA Botta","year":"1983","unstructured":"Botta, J. A., de Mendoza, D., Morero, R. D. & Far\u00edas, R. N. High affinity l-triiodothyronine binding sites on washed rat erythrocyte membranes. J. Biol. Chem. 258(11), 6690\u20136692 (1983).","journal-title":"J. Biol. Chem."},{"issue":"7","key":"4659_CR33","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1210\/en.2017-00250","volume":"158","author":"F Flamant","year":"2017","unstructured":"Flamant, F. et al. Thyroid hormone signaling pathways: Time for a more precise nomenclature. Endocrinology 158(7), 2052\u20132057. https:\/\/doi.org\/10.1210\/en.2017-00250 (2017).","journal-title":"Endocrinology"},{"issue":"4","key":"4659_CR34","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1152\/physrev.00002.2005","volume":"85","author":"JM Nerbonne","year":"2005","unstructured":"Nerbonne, J. M. & Kass, R. S. Molecular physiology of cardiac repolarization. Physiol. Rev. 85(4), 1205\u20131253 (2005).","journal-title":"Physiol. Rev."},{"issue":"2","key":"4659_CR35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1573403X12666160301120217","volume":"12","author":"LX Cubeddu","year":"2016","unstructured":"Cubeddu, L. X. Drug-induced inhibition and trafficking disruption of ion channels: Pathogenesis of QT abnormalities and drug-induced fatal arrhythmias. Curr. Cardiol. Rev. 12(2), 141\u2013154 (2016).","journal-title":"Curr. Cardiol. Rev."},{"issue":"5","key":"4659_CR36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.tcm.2014.02.001","volume":"24","author":"M Cerrone","year":"2014","unstructured":"Cerrone, M. & Delmar, M. Desmosomes and the sodium channel complex: Implications for arrhythmogenic cardiomyopathy and Brugada syndrome. Trends Cardiovasc. Med. 24(5), 184\u2013190 (2014).","journal-title":"Trends Cardiovasc. Med."},{"key":"4659_CR37","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3389\/fendo.2018.00642","volume":"9","author":"S Ducheix","year":"2018","unstructured":"Ducheix, S., Magr\u00e9, J., Cariou, B. & Prieur, X. Chronic O-GlcNAcylation and diabetic cardiomyopathy: The bitterness of glucose. Front. Endocrinol. 9, 642 (2018).","journal-title":"Front. Endocrinol."},{"issue":"1","key":"4659_CR38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13023-020-01465-x","volume":"15","author":"S Kou","year":"2020","unstructured":"Kou, S. et al. Patients with ACVR1R206H mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans Progressiva. Orphanet. J. Rare Dis. 15(1), 193 (2020).","journal-title":"Orphanet. J. Rare Dis."},{"issue":"8","key":"4659_CR39","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCRESAHA.110.220673","volume":"107","author":"M Liu","year":"2010","unstructured":"Liu, M., Liu, H. & Dudley, S. C. Jr. Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel. Circ. Res. 107(8), 967\u2013974 (2010).","journal-title":"Circ. Res."},{"issue":"4","key":"4659_CR40","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1152\/physrev.00037.2019","volume":"100","author":"R Papait","year":"2020","unstructured":"Papait, R., Serio, S. & Condorelli, G. Role of the epigenome in heart failure. Physiol. Rev. 100(4), 1753\u20131777 (2020).","journal-title":"Physiol. Rev."},{"key":"4659_CR41","unstructured":"https:\/\/maayanlab.cloud\/Harmonizome\/gene_set\/Long+QT+Syndrome\/CTD+Gene-Disease+Associations"},{"issue":"3","key":"4659_CR42","doi-asserted-by":"crossref","first-page":"100216","DOI":"10.1016\/j.xcrm.2021.100216","volume":"2","author":"P Mamoshina","year":"2021","unstructured":"Mamoshina, P., Rodriguez, B. & Bueno-Orovio, A. Toward a broader view of mechanisms of drug cardiotoxicity. Cell Rep. Med. 2(3), 100216 (2021).","journal-title":"Cell Rep. Med."},{"key":"4659_CR43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yjmcc.2018.05.005","volume":"120","author":"A Pott","year":"2018","unstructured":"Pott, A. et al. Mutation of the Na+\/K+-ATPase Atp1a1a.1 causes QT interval prolongation and bradycardia in zebrafish. J. Mol. Cell Cardiol. 120, 42\u201352 (2018).","journal-title":"J. Mol. Cell Cardiol."},{"issue":"6","key":"4659_CR44","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ajhg.2010.04.017","volume":"86","author":"Y Yang","year":"2010","unstructured":"Yang, Y. et al. Identification of a Kir3.4 mutation in congenital long QT syndrome. Am. J. Hum. Genet. 86(6), 872\u2013880 (2010).","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"4659_CR45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.362","volume":"41","author":"A Pfeufer","year":"2009","unstructured":"Pfeufer, A. et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat. Genet. 41(4), 407\u2013414 (2009).","journal-title":"Nat. Genet."},{"issue":"8","key":"4659_CR46","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ng.3014","volume":"46","author":"DE Arking","year":"2014","unstructured":"Arking, D. E. et al. Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. Nat. Genet. 46(8), 826\u2013836 (2014).","journal-title":"Nat. Genet."},{"issue":"2","key":"4659_CR47","doi-asserted-by":"crossref","first-page":"e13438","DOI":"10.1111\/apha.13438","volume":"229","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Alterations of Nedd4-2-binding capacity in PY-motif of NaV 1.5 channel underlie long QT syndrome and Brugada syndrome. Acta Physiol. 229(2), e13438 (2020).","journal-title":"Acta Physiol."},{"issue":"6","key":"4659_CR48","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/CIRCEP.111.969972","volume":"5","author":"T Ishikawa","year":"2012","unstructured":"Ishikawa, T. A novel disease gene for Brugada syndrome: Sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. Circ. Arrhythm. Electrophysiol. 5(6), 1098\u20131107 (2012).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"4659_CR49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/jhg.2008.16","volume":"54","author":"K Ueda","year":"2009","unstructured":"Ueda, K. et al. Role of HCN4 channel in preventing ventricular arrhythmia. J. Hum. Genet. 54, 115\u2013121 (2009).","journal-title":"J. Hum. Genet."},{"key":"4659_CR50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/hearts2030026","volume":"2","author":"E Lozano-Velasco","year":"2021","unstructured":"Lozano-Velasco, E., Aranega, A. & Franco, D. Non-coding RNAs in the cardiac action potential and their impact on arrhythmogenic cardiac diseases. Hearts 2, 307\u2013330 (2021).","journal-title":"Hearts"},{"issue":"1","key":"4659_CR51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/19336950.2018.1499368","volume":"12","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q., Chen, J., Qin, Y., Wang, J. & Zhou, L. Mutations in voltage-gated L-type calcium channel: Implications in cardiac arrhythmia. Channels 12(1), 201\u2013218 (2018).","journal-title":"Channels"},{"issue":"10","key":"4659_CR52","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.hrthm.2014.06.030","volume":"11","author":"JR Priest","year":"2014","unstructured":"Priest, J. R. et al. Molecular diagnosis of long QT syndrome at 10 days of life by rapid whole genome sequencing. Heart Rhythm 11(10), 1707\u20131713 (2014).","journal-title":"Heart Rhythm"},{"key":"4659_CR53","first-page":"834","volume":"13","author":"SF Qureshi","year":"2014","unstructured":"Qureshi, S. F. et al. Atrial natriuretic peptide gene\u2014A potential biomarker for long QT syndrome. EXCLI J. 13, 834\u2013842 (2014).","journal-title":"EXCLI J."},{"issue":"6","key":"4659_CR54","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.amjcard.2012.11.041","volume":"111","author":"B Vrtovec","year":"2013","unstructured":"Vrtovec, B. et al. Relation of B-type natriuretic peptide level in heart failure to sudden cardiac death in patients with and without QT interval prolongation. Am. J. Cardiol. 111(6), 886\u2013890 (2013).","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"4659_CR55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/105072502760143809","volume":"12","author":"WH Dillmann","year":"2002","unstructured":"Dillmann, W. H. Cellular action of thyroid hormone on the heart. Thyroid 12(6), 447\u2013452 (2002).","journal-title":"Thyroid"},{"key":"4659_CR56","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3389\/fphys.2020.00729","volume":"11","author":"K Wang","year":"2020","unstructured":"Wang, K. et al. BNP as a new biomarker of cardiac thyroid hormone function. Front. Physiol. 11, 729 (2020).","journal-title":"Front. Physiol."},{"issue":"1\u20132","key":"4659_CR57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1024153003249","volume":"247","author":"B Ziegelh\u00f6ffer-Mihalovicov\u00e1","year":"2003","unstructured":"Ziegelh\u00f6ffer-Mihalovicov\u00e1, B., Briest, W., Baba, H. A., Rassler, B. & Zimmer, H. G. The expression of mRNA of cytokines and of extracellular matrix proteins in triiodothyronine-treated rat hearts. Mol. Cell Biochem. 247(1\u20132), 61\u201368 (2003).","journal-title":"Mol. Cell Biochem."},{"key":"4659_CR58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.joa.2015.11.009","volume":"32","author":"JL Smith","year":"2016","unstructured":"Smith, J. L. et al. Molecular pathogenesis of long QT syndrome type 2. J. Arrhythm. 32, 373\u2013380 (2016).","journal-title":"J. Arrhythm."},{"issue":"1","key":"4659_CR59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccl.2008.09.005","volume":"27","author":"JE Finet","year":"2009","unstructured":"Finet, J. E., Rosenbaum, D. S. & Donahue, J. K. Information learned from animal models of atrial fibrillation. Cardiol. Clin. 27(1), 45\u201354 (2009).","journal-title":"Cardiol. Clin."},{"issue":"2","key":"4659_CR60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-2828(85)80015-8","volume":"17","author":"NA Sharp","year":"1985","unstructured":"Sharp, N. A., Neel, D. S. & Parsons, R. L. Influence of thyroid hormone levels on the electrical and mechanical properties of rabbit papillary muscle. J. Mol. Cell Cardiol. 17(2), 119\u2013132 (1985).","journal-title":"J. Mol. Cell Cardiol."},{"issue":"1","key":"4659_CR61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1540-8167.2002.00044.x","volume":"13","author":"C Johansson","year":"2002","unstructured":"Johansson, C., Koopmann, R., Vennstr\u00f6m, B. & Benndorf, K. Accelerated inactivation of voltage-dependent K+ outward current in cardiomyocytes from thyroid hormone receptor alpha1-deficient mice. J. Cardiovasc. Electrophysiol. 13(1), 44\u201350 (2002).","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"2","key":"4659_CR62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/bbrc.1997.7139","volume":"237","author":"S Shahrara","year":"1997","unstructured":"Shahrara, S., Drvota, V., Blange, I., T\u00f6rm\u00e4, H. & Sylv\u00e9n, C. Characterization of AT-1 cardiomyocytes as a model for studies of T3 effects on cardiac cells. Biochem. Biophys. Res. Commun. 237(2), 303\u2013306 (1997).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"4659_CR63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12967-019-1976-2","volume":"17","author":"CHC Leenaars","year":"2019","unstructured":"Leenaars, C. H. C. et al. Animal to human translation: A systematic scoping review of reported concordance rates. J. Transl. Med. 17(1), 223 (2019).","journal-title":"J. Transl. Med."},{"issue":"9","key":"4659_CR64","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.RES.0000018627.89528.6F","volume":"90","author":"G Schram","year":"2002","unstructured":"Schram, G., Pourrier, M., Melnyk, P. & Nattel, S. Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ. Res. 90(9), 939\u2013950 (2002).","journal-title":"Circ. Res."},{"key":"4659_CR65","doi-asserted-by":"crossref","first-page":"102418","DOI":"10.1016\/j.scr.2021.102418","volume":"54","author":"L Lavra","year":"2021","unstructured":"Lavra, L. et al. Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation. Stem Cell Res. 54, 102418 (2021).","journal-title":"Stem Cell Res."},{"key":"4659_CR66","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.yjmcc.2014.04.005","volume":"72","author":"X Yang","year":"2014","unstructured":"Yang, X. et al. Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J. Mol. Cell Cardiol. 72, 296\u2013304 (2014).","journal-title":"J. Mol. Cell Cardiol."},{"issue":"1","key":"4659_CR67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.117.305365","volume":"117","author":"I Karakikes","year":"2015","unstructured":"Karakikes, I., Ameen, M., Termglinchan, V. & Wu, J. C. Human induced pluripotent stem cell-derived cardiomyocytes: Insights into molecular, cellular, and functional phenotypes. Circ. Res. 117(1), 80\u201388 (2015).","journal-title":"Circ. Res."},{"issue":"6","key":"4659_CR68","doi-asserted-by":"crossref","first-page":"H913","DOI":"10.1152\/ajpheart.00819.2012","volume":"305","author":"CY Ivashchenko","year":"2013","unstructured":"Ivashchenko, C. Y. et al. Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. Am. J. Physiol. Heart Circ. Physiol. 305(6), H913\u2013H922 (2013).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"4659_CR69","doi-asserted-by":"crossref","first-page":"13188","DOI":"10.1038\/s41598-019-49653-5","volume":"9","author":"N Kumar","year":"2019","unstructured":"Kumar, N. et al. Assessment of temporal functional changes and miRNA profiling of human iPSC-derived cardiomyocytes. Sci. Rep. 9(1), 13188 (2019).","journal-title":"Sci. Rep."},{"issue":"8","key":"4659_CR70","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1089\/thy.2019.0763","volume":"30","author":"S Minakhina","year":"2020","unstructured":"Minakhina, S. et al. A direct comparison of thyroid hormone receptor protein levels in mice provides unexpected insights into thyroid hormone action. Thyroid 30(8), 1193\u20131204 (2020).","journal-title":"Thyroid"},{"issue":"1","key":"4659_CR71","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/JOE-17-0708","volume":"237","author":"CS Anyetei-Anum","year":"2018","unstructured":"Anyetei-Anum, C. S., Roggero, V. R. & Allison, L. A. Localization of thyroid hormone receptor in target tissues. J. Endocrinol. 237(1), R19\u2013R34 (2018).","journal-title":"J. Endocrinol."},{"issue":"1","key":"4659_CR72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1172\/JCI62928","volume":"123","author":"AL George Jr","year":"2013","unstructured":"George, A. L. Jr. Molecular and genetic basis of sudden cardiac death. J. Clin. Investig. 123(1), 75\u201383 (2013).","journal-title":"J. Clin. Investig."},{"issue":"1\u20133","key":"4659_CR73","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pbiomolbio.2015.11.003","volume":"120","author":"J N\u011bmec","year":"2016","unstructured":"N\u011bmec, J., Kim, J. J. & Salama, G. The link between abnormal calcium handling and electrical instability in acquired long QT syndrome\u2014Does calcium precipitate arrhythmic storms?. Prog. Biophys. Mol. Biol. 120(1\u20133), 210\u2013221 (2016).","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"12","key":"4659_CR74","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/CIRCRESAHA.116.305017","volume":"116","author":"H Abriel","year":"2015","unstructured":"Abriel, H., Rougier, J. S. & Jalife, J. Ion channel macromolecular complexes in cardiomyocytes: Roles in sudden cardiac death. Circ. Res. 116(12), 1971\u20131988 (2015).","journal-title":"Circ. Res."},{"key":"4659_CR75","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3389\/fendo.2019.00601","volume":"10","author":"F Forini","year":"2019","unstructured":"Forini, F., Nicolini, G., Pitto, L. & Iervasi, G. Novel insight into the epigenetic and post-transcriptional control of cardiac gene expression by thyroid hormone. Front. Endocrinol. 10, 601 (2019).","journal-title":"Front. Endocrinol."},{"key":"4659_CR76","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.3390\/cells10092417","volume":"10","author":"CE Blandin","year":"2021","unstructured":"Blandin, C. E., Gravez, B. J., Hatem, S. N. & Balse, E. Remodeling of ion channel trafficking and cardiac arrhythmias. Cells 10, 2417 (2021).","journal-title":"Cells"},{"key":"4659_CR77","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1042\/BST0351060","volume":"35","author":"A Dennis","year":"2007","unstructured":"Dennis, A., Wang, L., Wan, X. & Ficker, E. hERG channel trafficking: Novel targets in drug-induced long QT syndrome. Biochem. Soc. Trans. 35, 1060\u20131063 (2007).","journal-title":"Biochem. Soc. Trans."},{"key":"4659_CR78","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.104.073692","volume":"312","author":"YA Kuryshev","year":"2005","unstructured":"Kuryshev, Y. A. et al. Pentamidine-induced long QT syndrome and block of hERG trafficking. J. Pharmacol. Exp. Ther. 312, 316\u2013323 (2005).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"4659_CR79","doi-asserted-by":"crossref","first-page":"106738","DOI":"10.1016\/j.vascn.2020.106738","volume":"105","author":"S Guilbot","year":"2020","unstructured":"Guilbot, S., Morton, M., Printemps, R. & Le Grand, M. Evaluation of two hERG channel trafficking modulators, pentamidine and pilsicainide, on stably transfected cell line and human induced pluripotent stem cell-derived cardiomyocytes. J. Pharmacol. Toxicol. Methods. 105, 106738 (2020).","journal-title":"J. Pharmacol. Toxicol. Methods."},{"key":"4659_CR80","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.vascn.2015.12.002","volume":"78","author":"T Kitaguchi","year":"2016","unstructured":"Kitaguchi, T. et al. CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia\u2014Effects of 7 reference compounds at 10 facilities. J. Pharmacol. Toxicol. Methods. 78, 93\u2013102 (2016).","journal-title":"J. Pharmacol. Toxicol. Methods."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04659-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04659-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04659-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T20:38:19Z","timestamp":1669322299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04659-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4659"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-04659-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,12]]},"assertion":[{"value":"24 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"568"}}